FR2274309B1 - - Google Patents

Info

Publication number
FR2274309B1
FR2274309B1 FR7509621A FR7509621A FR2274309B1 FR 2274309 B1 FR2274309 B1 FR 2274309B1 FR 7509621 A FR7509621 A FR 7509621A FR 7509621 A FR7509621 A FR 7509621A FR 2274309 B1 FR2274309 B1 FR 2274309B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7509621A
Other languages
French (fr)
Other versions
FR2274309A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plurichemie Anstalt
Original Assignee
Plurichemie Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plurichemie Anstalt filed Critical Plurichemie Anstalt
Publication of FR2274309A1 publication Critical patent/FR2274309A1/en
Application granted granted Critical
Publication of FR2274309B1 publication Critical patent/FR2274309B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7509621A 1974-03-27 1975-03-27 NEW STEROIDS AND THEIR PREPARATION Granted FR2274309A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT6163774 1974-03-27
PT6163674 1974-03-27
PT6163675 1975-03-10

Publications (2)

Publication Number Publication Date
FR2274309A1 FR2274309A1 (en) 1976-01-09
FR2274309B1 true FR2274309B1 (en) 1978-11-24

Family

ID=27354092

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7509621A Granted FR2274309A1 (en) 1974-03-27 1975-03-27 NEW STEROIDS AND THEIR PREPARATION

Country Status (8)

Country Link
BE (1) BE827275A (en)
CH (2) CH622811A5 (en)
DK (1) DK153556C (en)
FR (1) FR2274309A1 (en)
GB (2) GB1511820A (en)
IE (2) IE41138B1 (en)
NZ (1) NZ177056A (en)
SE (1) SE440656B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (en) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 Preparation method for micronised be clomethasone dispropionate mono-hydrate
IT1285770B1 (en) 1996-10-04 1998-06-18 Nicox Sa CORTICOID COMPOUNDS
CN102516348B (en) * 2011-11-10 2013-11-13 中国科学院上海有机化学研究所 16S-Methyl-20S-droxypregna compound, and synthesis method and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070751A (en) * 1964-01-28 1967-06-01 Glaxo Lab Ltd 17-esters of 17-hydroxy-21-desoxy-steroids
GB1139505A (en) * 1965-06-23 1969-01-08 Glaxo Lab Ltd A process for the production of 17-‡-monoesters of 17-‡-hydroxy-20-keto-steroids
CH481085A (en) * 1965-08-30 1969-11-15 Scherico Ltd Process for the preparation of 11B-hydroxy-17 -alkanoyloxysteroids of the pregnane series
US3383394A (en) * 1965-08-30 1968-05-14 Schering Corp Novel 17-acylating process and products thereof
BE788355A (en) * 1971-09-07 1973-03-05 Merck Patent Gmbh 9 ALPHA-FLUORO-16-METHYLENE-PREDNISOLONE ESTERS

Also Published As

Publication number Publication date
IE41137L (en) 1975-09-27
GB1511820A (en) 1978-05-24
DK153556C (en) 1988-12-05
NZ177056A (en) 1978-09-20
IE41138B1 (en) 1979-10-24
DK129575A (en) 1975-09-28
BE827275A (en) 1975-07-16
DK153556B (en) 1988-07-25
CH622811A5 (en) 1981-04-30
SE7803041L (en) 1978-03-16
GB1510617A (en) 1978-05-10
CH625254A5 (en) 1981-09-15
FR2274309A1 (en) 1976-01-09
IE41137B1 (en) 1979-10-24
SE440656B (en) 1985-08-12

Similar Documents

Publication Publication Date Title
AR199089A1 (en)
AU495844B2 (en)
AU7474374A (en)
AU479987A (en)
AU480170A (en)
BG19607A1 (en)
BG20018A1 (en)
BG20186A1 (en)
BG20662A1 (en)
BG20665A1 (en)
BG20670A1 (en)
BG20724A1 (en)
BG20849A1 (en)
BG21661A1 (en)
BG21791A1 (en)
BG22011A1 (en)
BG22387A3 (en)
BG22667A1 (en)
BG26192A3 (en)
BG26358A3 (en)
BG26402A3 (en)
BG27047A4 (en)
BG27089A3 (en)
CH1637174A4 (en)
CH352875A4 (en)